XBIT - XBiotech Inc Stock Price, Fair Value and News

$6.38+0.04 (+0.63%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

XBIT Price Action

Last 7 days

-8.2%

Last 30 days

-1.7%

Last 90 days

-6.0%

Trailing 12 Months

59.9%

XBIT RSI Chart

XBIT Valuation

Market Cap

194.5M

Price/Earnings (Trailing)

-5.96

Price/Sales (Trailing)

18.85

EV/EBITDA

-0.37

Price/Free Cashflow

-6.66

XBIT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

XBIT Fundamentals

XBIT Revenue

Revenue (TTM)

10.3M

Rev. Growth (Yr)

-6.33%

Rev. Growth (Qtr)

-11.9%

XBIT Earnings

Earnings (TTM)

-32.7M

Earnings Growth (Yr)

31.9%

Earnings Growth (Qtr)

61.44%

XBIT Profitability

EBT Margin

-317.34%

Return on Equity

-17%

Return on Assets

-15.56%

Free Cashflow Yield

-15.01%

XBIT Investor Care

Shares Dilution (1Y)

0.15%

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	10.3M	10.5M	10.3M	0
2023	7.8M	8.8M	10.3M	10.4M
2022	14.8M	11.1M	7.5M	3.8M
2021	36.2M	25.2M	19.2M	18.4M
2020	17.9M	26.6M	35.3M	44.0M
2019	414.5K	358.5K	508.5K	9.2M
2018	368.5K	361.5K	338.5K	400.5K
2017	125.1K	201.3K	277.4K	353.5K
2016	0	0	0	49.0K
2015	0	0	0	0
2014	0	0	0	0
2013	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

About XBiotech Inc

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

CEO	Mr. John Simard
WEBSITE	xbiotech.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	84

XBiotech Inc Frequently Asked Questions

What is the ticker symbol for XBiotech Inc? What does XBIT stand for in stocks?

XBIT is the stock ticker symbol of XBiotech Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of XBiotech Inc (XBIT)?

As of Fri Dec 20 2024, market cap of XBiotech Inc is 194.48 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of XBIT stock?

You can check XBIT's fair value in chart for subscribers.

Is XBiotech Inc a good stock to buy?

The fair value guage provides a quick view whether XBIT is over valued or under valued. Whether XBiotech Inc is cheap or expensive depends on the assumptions which impact XBiotech Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for XBIT.

What is XBiotech Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, XBIT's PE ratio (Price to Earnings) is -5.96 and Price to Sales (PS) ratio is 18.85. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. XBIT PE ratio will change depending on the future growth rate expectations of investors.